The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Endosomal escape pathways for delivery of biologicals
Open accessAbstract
Despite continuous improvements in delivery systems, the development of methods for efficient and specific delivery of targeted therapeutic agents still remains an issue in biological treatments such as protein and gene therapy. The endocytic pathway is the major uptake mechanism of cells and any biological agents, such as DNA, siRNA and proteins. These agents become entrapped in endosomes and are degraded by specific enzymes in the lysosome. Thus, a limiting step in achieving an effective biological based therapy is to facilitate the endosomal escape and ensure cytosolic delivery of the therapeutics. Bacteria and viruses are pathogens which use different mechanisms to penetrate the membranes of their target cells and escape the endosomal pathway. Different mechanisms such as pore formation in the endosomal membrane, pH-buffering effect of protonable groups and fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal escape. Several viral and bacterial proteins have been identified that are involved in this process. In addition, chemical agents and photochemical methods to rupture the endosomal membrane have been described. New synthetic biomimetic peptides and polymers with high efficacy in facilitating the endosomal escape, low pathogenicity and toxicity have been developed. Each strategy has different characteristics and challenges for designing the best agents and techniques to facilitate the endosomal escape are ongoing. In this review, several mechanisms and agents which are involved in endosomal escape are introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,605
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,045
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
The actions of melittin on membranes
Dempsey, C. E. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90006-x · Cited by 852
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P. C., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Flagged first, then by citations
3 of the 151 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,774
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Cell-Penetrating Peptides: From Basic Research to Clinics
Guidotti, G., Brambilla, L., & Rossi, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.01.003 · Cited by 1,192
DNA Nanotechnology-Enabled Drug Delivery Systems
Hu, Q., Li, H., Wang, L., Gu, H., & Fan, C. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00663 · Cited by 1,140
Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
Argyo, C., Weiß, V., Bräuchle, C., & Bein, T. (2013) · Chemistry of Materials · doi:10.1021/cm402592t · Cited by 922
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 882
Cell‐penetrating peptides: 20 years later, where do we stand?
Bechara, C., & Sagan, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.031 · Cited by 906
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 909
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Hildebrandt, N., Spillmann, C. M., Algar, W. R., Pons, T., Stewart, M. H., Oh, E., Susumu, K., Díaz, S. A., Delehanty, J. B., & Medintz, I. L. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00030 · Cited by 748
Li, Z., Lai, X., Fu, S., Ren, L. F., Cai, H., Zhang, H., Gu, Z., Ma, X., & Luo, K. (2022) · Advanced Science · doi:10.1002/advs.202201734 · Cited by 704
Self‐assembled DNA nanoclews for the efficient delivery of CRISPR–Cas9 for genome editing
Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506030 · Cited by 629
Lipids and Lipid Derivatives for RNA Delivery
Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 649
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Billingsley, M. M., Singh, N., Ravikumar, P., Zhang, R., June, C. H., & Mitchell, M. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04246 · Cited by 636
Advances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
Therapeutic in vivo delivery of gene editing agents
Raguram, A., Banskota, S., & Liu, D. R. (2022) · Cell · doi:10.1016/j.cell.2022.03.045 · Cited by 552
Joga, M. R., Zotti, M. J., Smagghe, G. J., & Christiaens, O. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00553 · Cited by 564
A vector-free microfluidic platform for intracellular delivery
Sharei, A., Zoldan, J., Adamo, A., Sim, W. Y., Cho, N., Jackson, E., Mao, S., Schneider, S., Han, M.-J., Lytton‐Jean, A. K. R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218705110 · Cited by 497
Pi, F., Binzel, D. W., Lee, T. J., Li, Z., Sun, M., Rychahou, P. G., Li, H., Haque, F., Wang, S., Croce, C. M., et al. (2017) · Nature Nanotechnology · doi:10.1038/s41565-017-0012-z · Cited by 499
Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell
Manzanares, D., & Ceña, V. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040371 · Cited by 503
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X., Xu, X., Bertrand, N., Pridgen, E. M., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 494
MicroRNA delivery through nanoparticles
Lee, S. W. L., Paoletti, C., Campisi, M., Osaki, T., Adriani, G., Kamm, R. D., Mattu, C., & Chiono, V. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.007 · Cited by 455
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
Zhang, S., Shen, J., Li, D., & Cheng, Y. (2021) · Theranostics · doi:10.7150/thno.47007 · Cited by 430
Drug delivery to the central nervous system
Nance, E. A., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 442
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415
The great escape: how cationic polyplexes overcome the endosomal barrier
Buś, T., Traeger, A., & Schubert, U. S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00967h · Cited by 422
Overcoming Endosomal Entrapment in Drug Delivery
Pei, D., & Buyanova, M. Y. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00778 · Cited by 418
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
Gu, L., & Mooney, D. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.3 · Cited by 407
Moreno, M. R., & Giralt, E. (2015) · Toxins · doi:10.3390/toxins7041126 · Cited by 399
Cheng, G., Li, W., Ha, L., Han, X., Hao, S., Wan, Y., Wang, Z., Dong, F., Zou, X., Mao, Y., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03584 · Cited by 371
Targeted gene silencing in vivo by platelet membrane–coated metal-organic framework nanoparticles
Zhuang, J., Gong, H., Zhou, J., Zhang, Q., Gao, W., Fang, R. H., & Zhang, L. (2020) · Science Advances · doi:10.1126/sciadv.aaz6108 · Cited by 366
Evans, B. C., Nelson, C. E., Yu, S. S., Beavers, K. R., Kim, A. J., Li, H., Nelson, H. M., Giorgio, T. D., & Duvall, C. L. (2013) · Journal of Visualized Experiments · doi:10.3791/50166 · Cited by 356
Polyethylenimine (PEI) in gene therapy: Current status and clinical applications
Casper, J., Schenk, S., Parhizkar, E., Detampel, P., Dehshahri, A., & Huwyler, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.001 · Cited by 360
The proton sponge hypothesis: Fable or fact?
Vermeulen, L. M. P., Smedt, S. C. D., Remaut, K., & Braeckmans, K. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.034 · Cited by 355
Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications
Bazban‐Shotorbani, S., Hasani‐Sadrabadi, M. M., Karkhaneh, A., Serpooshan, V., Jacob, K. I., Moshaverinia, A., & Mahmoudi, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.021 · Cited by 346
Intracellular delivery of nanomaterials: How to catch endosomal escape in the act
Martens, T., Remaut, K., Demeester, J., Smedt, S. C. D., & Braeckmans, K. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.011 · Cited by 342
pH ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
Karimi, M., Eslami, M., Sahandi‐Zangabad, P., Mirab, F., Farajisafiloo, N., Shafaei, Z., Ghosh, D., Bozorgomid, M., Dashkhaneh, F., & Hamblin, M. R. (2016) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1389 · Cited by 327
Acoustically Propelled Nanomotors for Intracellular siRNA Delivery
de Ávila, B. E., Angell, C., Soto, F., Lopez‐Ramirez, M. A., Báez, D. F., Xie, S., Wang, J., & Chen, Y. (2016) · ACS Nano · doi:10.1021/acsnano.6b01415 · Cited by 309
Challenges in design and characterization of ligand-targeted drug delivery systems
Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 312
Yan, S., Ren, B., & Shen, J. (2020) · Insect Science · doi:10.1111/1744-7917.12822 · Cited by 321
Mechanisms of secretion and spreading of pathological tau protein
Brunello, C. A., Merezhko, M., Uronen, R.-L., & Huttunen, H. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03349-1 · Cited by 304
Cell-Penetrating Peptides: Design Strategies beyond Primary Structure and Amphipathicity
Kalafatović, D., & Giralt, E. (2017) · Molecules · doi:10.3390/molecules22111929 · Cited by 314
Biophysical insight into mechanisms of sonoporation
Helfield, B. L., Chen, X., Watkins, S. C., & Villanueva, F. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606915113 · Cited by 302
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Kim, B., Park, J., & Sailor, M. J. (2019) · Advanced Materials · doi:10.1002/adma.201903637 · Cited by 307
Discovery and Mechanism of Highly Efficient Cyclic Cell-Penetrating Peptides
Qian, Z., Martyna, A., Hard, R. L., Wang, J., Appiah‐Kubi, G., Coss, C. C., Phelps, M. A., Rossman, J. S., & Pei, D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00226 · Cited by 301
Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents
Borrelli, A., Tornesello, A. L., Tornesello, M. L., & Buonaguro, F. M. (2018) · Molecules · doi:10.3390/molecules23020295 · Cited by 310
Preclinical and Clinical Advances of GalNAc-Decorated Nucleic Acid Therapeutics
Huang, Y. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.003 · Cited by 299
RNAi therapeutic and its innovative biotechnological evolution
Weng, Y., Xiao, H., Zhang, J., Liang, X., & Huang, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.012 · Cited by 293
Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics
Lorenzer, C., Dirin, M., Winkler, A.-M., Baumann, V., & Winkler, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.02.003 · Cited by 284
“The endocytic vessels fuse with endosomes, and for successfully attaining the siRNA machinery, the oligonucleotides still have to pass through this last barrier [72,73].”
BackgroundInvestigating the pharmacodynamic durability of GalNAc–siRNA conjugates
Brown, C. R., Gupta, S., Qin, J., Racie, T., He, G., Lentini, S., Malone, R., Yu, M., Matsuda, S., Shulga-Morskaya, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa670 · Cited by 285
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles
FitzGerald, L. I., Cortez‐Jugo, C., Such, G. K., & Johnston, A. P. R. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1452 · Cited by 293
Magnetic Nanoparticles in Targeted Drug Delivery: a Review
Kianfar, E. (2021) · Journal of Superconductivity and Novel Magnetism · doi:10.1007/s10948-021-05932-9 · Cited by 293
Influencing factors and strategies of enhancing nanoparticles into tumors in vivo
Zhang, M., Gao, S., Yang, D., Fang, Y., Lin, X., Jin, X., Liu, Y., Liu, X., Su, K., & Shi, K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.033 · Cited by 281
Organelle targeting: third level of drug targeting
Padh, H., & Sakhrani, N. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s45614 · Cited by 278
Multifunctional Efficiency: Extending the Concept of Atom Economy to Functional Nanomaterials
Freund, R., Lächelt, U., Gruber, T., Rühle, B., & Wuttke, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b00932 · Cited by 266
Exocytosis of nanoparticles from cells: Role in cellular retention and toxicity
Sakhtianchi, R., Minchin, R. F., Lee, K., Alkilany, A. M., Serpooshan, V., & Mahmoudi, M. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.10.013 · Cited by 271
Challenges in design of translational nanocarriers
Sun, Q., Radosz, M., & Shen, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.042 · Cited by 266
Ding, H., & Ma, Y. (2014) · Small · doi:10.1002/smll.201401943 · Cited by 265
Non-viral Delivery of Nucleic Acids: Insight Into Mechanisms of Overcoming Intracellular Barriers
Durymanov, M. O., & Reineke, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00971 · Cited by 267
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Sajid, M. I., Moazzam, M., Kato, S., Cho, K. Y., & Tiwari, R. K. (2020) · Pharmaceuticals · doi:10.3390/ph13100294 · Cited by 262
Multifunctional carbon dots with high quantum yield for imaging and gene delivery
Hu, L., Sun, Y., Li, S., Wang, X., Hu, K., Wang, L., Liang, X., & Wu, Y. F. (2013) · Carbon · doi:10.1016/j.carbon.2013.10.023 · Cited by 253
Boosting intracellular delivery of lipid nanoparticle-encapsulated mRNA
Patel, S., Ashwanikumar, N., Robinson, E., DuRoss, A., Sun, C., Murphy-Benenato, K. E., Mihai, C., Almarsson, Ö., & Sahay, G. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b02664 · Cited by 251
Different strategies to overcome multidrug resistance in cancer
Manju, S., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 259
Benne, N., van Duijn, J., Kuiper, J., Jiskoot, W., & Slütter, B. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.033 · Cited by 247
Engineering siRNA therapeutics: challenges and strategies
Zaidi, S. S. A., Fatima, F., Zaidi, S. A. A., Zhou, D., Deng, W., & Liu, S. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02147-z · Cited by 280
Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release
Aghdam, M. A., Bagheri, R., Mosafer, J., Baradaran, B., Hashemzaei, M., Baghbanzadeh, A., de la Guárdia, M., & Mokhtarzadeh, A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.09.018 · Cited by 242
Xu, L., Chen, Y., Wang, M., Ma, Y., Xia, W., & Gu, H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.072 · Cited by 245
Enhanced Endosomal Escape by Light-Fueled Liquid-Metal Transformer
Lü, Y., Lin, Y., Chen, Z., Hu, Q., Liu, Y., Yu, S., Gao, W., Dickey, M. D., & Gu, Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04346 · Cited by 241
Yu, H., Zou, Y., Wang, Y., Huang, X., Huang, G., Sumer, B. D., Boothman, D. A., & Gao, J. (2011) · ACS Nano · doi:10.1021/nn203503h · Cited by 239
Farjadian, F., Roointan, A., Mohammadi‐Samani, S., & Hosseini, M. H. (2018) · Chemical Engineering Journal · doi:10.1016/j.cej.2018.11.156 · Cited by 248
Cancer-Cell-Membrane-Coated Nanoparticles with a Yolk–Shell Structure Augment Cancer Chemotherapy
Nie, D., Dai, Z., Li, J., Yang, Y., Xi, Z., Wang, J., Zhang, W., Qian, K., Guo, S., Zhu, C., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03817 · Cited by 228
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 241
Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy
Mainini, F., & Eccles, M. R. (2020) · Molecules · doi:10.3390/molecules25112692 · Cited by 228
Liu, Y., Wang, W., Yang, J., Zhou, C., & Sun, J. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.021 · Cited by 224
Current Development of siRNA Bioconjugates: From Research to the Clinic
Chernikov, I. V., Vlassov, V. V., & Chernolovskaya, E. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00444 · Cited by 221
Endosomal Size and Membrane Leakiness Influence Proton Sponge-Based Rupture of Endosomal Vesicles
Vermeulen, L. M. P., Brans, T., Samal, S. K., Dubruel, P., Demeester, J., Smedt, S. C. D., Remaut, K., & Braeckmans, K. (2018) · ACS Nano · doi:10.1021/acsnano.7b07583 · Cited by 218
Gessner, I., & Neundorf, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072536 · Cited by 212
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
Song, X., Liu, C., Wang, N., Huang, H., He, S., Gong, C., & Wei, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.010 · Cited by 217
A review of the current status of siRNA nanomedicines in the treatment of cancer
Resnier, P., Montier, T., Mathieu, V., Benoît, J., & Passirani, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.060 · Cited by 214
Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic
van den Berg, A. I. S., Yun, C., Schiffelers, R. M., & Hennink, W. E. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.014 · Cited by 215
Protein delivery into cells using inorganic nanoparticle–protein supramolecular assemblies
Scaletti, F., Hardie, J., Lee, Y.-W., Luther, D. C., Ray, M., & Rotello, V. M. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00008e · Cited by 208
ASSANHOU, A. G., Li, W., Zhang, L., Xue, L., Kong, L., Sun, H., Mo, R., & Zhang, C. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.09.022 · Cited by 208
Targeted therapy for cancer using pH-responsive nanocarrier systems
Manchun, S., Dass, C. R., & Sriamornsak, P. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.01.008 · Cited by 208
Multi-functionalized carbon dots as theranostic nanoagent for gene delivery in lung cancer therapy
Wu, Y., Wu, H., Kuan, C., Lin, C.-J., Wang, L.-W., Chang, C., & Wang, T. (2016) · Scientific Reports · doi:10.1038/srep21170 · Cited by 208
Kamaruzzaman, N. F., Kendall, S. L., & Good, L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13664 · Cited by 205
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management
Huo, D., Jiang, X., & Hu, Y. (2019) · Advanced Materials · doi:10.1002/adma.201904337 · Cited by 207
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Zhou, J., Shum, K., Burnett, J., & Rossi, J. J. (2013) · Pharmaceuticals · doi:10.3390/ph6010085 · Cited by 211
Theoretical and computational studies of dendrimers as delivery vectors
Tian, W., & Ma, Y. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35306g · Cited by 204
Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems
Shi, B., Zheng, M., Tao, W., Chung, R. S., Jin, D., Ghaffari, D., & Farokhzad, O. C. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00803 · Cited by 206
The new era of nanotechnology, an alternative to change cancer treatment
Jurj, A. M., Braicu, C., Pop, L., Tomuleasa, C., Gherman, C. D., & Berindan‐Neagoe, I. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s142337 · Cited by 203
(Macro)molecular self-assembly for hydrogel drug delivery
Webber, M. J., & Pashuck, E. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.006 · Cited by 204
Xiong, R., Raemdonck, K., Peynshaert, K., Lentacker, I., Cock, I. D., Demeester, J., Smedt, S. C. D., Skirtach, A. G., & Braeckmans, K. (2014) · ACS Nano · doi:10.1021/nn5017742 · Cited by 195
Buckton, L. K., Rahimi, M. N., & McAlpine, S. R. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905385 · Cited by 195
Kim, J., Kim, H., & Kim, W. J. (2015) · Small · doi:10.1002/smll.201501655 · Cited by 194
Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery
Raemdonck, K., Braeckmans, K., Demeester, J., & Smedt, S. C. D. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60299k · Cited by 192
Komin, A., Russell, L. M., Hristova, K. A., & Searson, P. C. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.002 · Cited by 193
Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery
Alabi, C. A., Love, K. T., Sahay, G., Yin, H., Luly, K. M., Langer, R., & Anderson, D. G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306529110 · Cited by 188
Nanoparticles: Cellular Uptake and Cytotoxicity
Adjei, I. M., Sharma, B., & Labhasetwar, V. D. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8739-0_5 · Cited by 195
Applications and challenges of ultra-small particle size nanoparticles in tumor therapy
Xu, J., Song, M., Zhou, F., Zheng, L., Huang, X., & Liu, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.028 · Cited by 188
Metadata
- Authors
- Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J.
- Affiliations
- Utrecht University (NL)
- University of Groningen (NL)
- Corresponding author
- Haisma, Hidde J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 151
- Issue
- 3
- Pages
- 220-228
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2008028087
- Cited by
- 1,561
- References
- 151
- Citations by year
- 2026: 82 · 2025: 82 · 2024: 90 · 2023: 94 · 2022: 122 · 2021: 100 · 2020: 123 · 2019: 120 · 2018: 137 · 2017: 111 · 2016: 127 · 2015: 116 · 2014: 98 · 2013: 90 · 2012: 51
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- endosomal escape, endocytosis, lysosomal degradation, protein delivery, gene delivery, siRNA delivery, viral fusion, pH buffering, biomimetic peptides, polymers, biologic therapy
- MeSH terms
- Animals, Cytosol, DNA, Drug Carriers, Endocytosis, Humans, Intracellular Membranes, Membrane Fusion, Models, Biological, Proteins, Endosomes, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
